September 1 – The National Development and Reform Commission  reduced prices of 82 types of medicine by an average of 14 percent today, reports the Beijing Morning Post. The measure is expected to affect more than 400 preparations currently sold on the market.

Medicines affected by the price adjustment include treatments for the endocrine system as well as hormone and brain medicines.

Shares of Nanjing Pharmaceutical Company (600713) fell 0.78 percent to trade at 6.33 yuan at close today.